{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T03:48:59Z","timestamp":1785383339208,"version":"3.55.0"},"reference-count":24,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["aacejournalendocrinepractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrine Practice"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.4158\/ep-2018-0489","type":"journal-article","created":{"date-parts":[[2019,1,18]],"date-time":"2019-01-18T11:15:08Z","timestamp":1547810108000},"page":"470-476","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Biochemical Dynamics of Untreated Primary Hyperparathyroidism: an Observational Study"],"prefix":"10.1016","volume":"25","author":[{"given":"Michael W.","family":"Yeh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric J.","family":"Kuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annette L.","family":"Adams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip I.","family":"Haigh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.4158\/EP-2018-0489_bb0010","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1210\/jc.2012-4022","article-title":"Incidence and prevalence of primary hyperparathyroidism in a racially mixed population","volume":"98","author":"Yeh","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"issue":"suppl 2","key":"10.4158\/EP-2018-0489_bb0015","doi-asserted-by":"crossref","first-page":"S85","DOI":"10.1002\/jbmr.5650061419","article-title":"Characterization and evaluation of asymptomatic primary hyperparathyroidism","volume":"6","author":"Bilezikian","year":"1991","journal-title":"J Bone Miner Res"},{"key":"10.4158\/EP-2018-0489_bb0020","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1056\/NEJM199910213411701","article-title":"A 10-year prospective study of primary hyperparathyroidism with or without parathyroid surgery","volume":"341","author":"Silverberg","year":"1999","journal-title":"N Engl J Med"},{"key":"10.4158\/EP-2018-0489_bb0025","doi-asserted-by":"crossref","first-page":"3462","DOI":"10.1210\/jc.2007-1215","article-title":"The natural history of primary hyperparathyroidism with or without parathyroid surgery after 15 years","volume":"93","author":"Rubin","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP-2018-0489_bb0030","doi-asserted-by":"crossref","first-page":"4324","DOI":"10.1210\/jc.2009-2819","article-title":"Underutilization of parathyroidectomy in elderly patients with primary hyperparathyroidism","volume":"95","author":"Wu","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP-2018-0489_bb0035","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1097\/SLA.0b013e31824dad7d","article-title":"Surgery for primary hyperparathyroidism: are the consensus guidelines being followed?","volume":"255","author":"Yeh","year":"2012","journal-title":"Ann Surg"},{"key":"10.4158\/EP-2018-0489_bb0040","doi-asserted-by":"crossref","first-page":"715","DOI":"10.7326\/M15-1232","article-title":"The relationship of parathyroidectomy and bisphosphonates with fracture risk in primary hyperparathyroidism: an observational study","volume":"164","author":"Yeh","year":"2016","journal-title":"Ann Intern Med"},{"key":"10.4158\/EP-2018-0489_bb0045","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0002-9343(97)00270-2","article-title":"Survival after the diagnosis of hyperparathyroidism: a population-based study","volume":"104","author":"Wermers","year":"1998","journal-title":"Am J Med"},{"key":"10.4158\/EP-2018-0489_bb0050","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1359\/jbmr.1999.14.10.1700","article-title":"Primary hyperparathyroidism and the risk of fracture: a population-based study","volume":"14","author":"Khosla","year":"1999","journal-title":"J Bone Miner Res"},{"key":"10.4158\/EP-2018-0489_bb0055","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1359\/JBMR.050910","article-title":"Incidence of primary hyperparathyroidism in Rochester, Minnesota, 1993\u20132001: an update on the changing epidemiology of the disease","volume":"21","author":"Wermers","year":"2006","journal-title":"J Bone Miner Res"},{"key":"10.4158\/EP-2018-0489_bb0060","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1111\/j.1365-2265.2008.03520.x","article-title":"Epidemiology of primary hyperparathyroidism in Tayside, Scotland, UK","volume":"71","author":"Yu","year":"2009","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.4158\/EP-2018-0489_bb0065","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1111\/j.1365-2265.2010.03958.x","article-title":"A record linkage study of outcomes in patients with mild primary hyperparathyroidism: the Parathyroid Epidemiology and Audit Research Study (PEARS)","volume":"75","author":"Yu","year":"2011","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.4158\/EP-2018-0489_bb0070","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1093\/qjmed\/hcq261","article-title":"The natural history of treated and untreated primary hyperparathyroidism: the parathyroid epidemiology and audit research study","volume":"104","author":"Yu","year":"2011","journal-title":"QJM"},{"key":"10.4158\/EP-2018-0489_bb0075","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.surg.2018.04.088","article-title":"End-organ effects of primary hyperparathyroidism: a population-based study","volume":"165","author":"Assadipour","year":"2019","journal-title":"Surgery"},{"key":"10.4158\/EP-2018-0489_bb0080","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1210\/jc.2006-1836","article-title":"Medical observation, compared with parathyroidectomy, for asymptomatic primary hyperparathyroidism: a prospective, randomized trial","volume":"92","author":"Bollerslev","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP-2018-0489_bb0085","doi-asserted-by":"crossref","first-page":"3114","DOI":"10.1210\/jc.2007-0219","article-title":"Surgery or surveillance for mild asymptomatic primary hyperparathyroidism: a prospective, randomized clinical trial","volume":"92","author":"Ambrogini","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP-2018-0489_bb0090","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1210\/jcem-67-6-1294","article-title":"Lack of biochemical progression or continuation of accelerated bone loss in mild asymptomatic primary hyperparathyroidism: evidence for biphasic disease course","volume":"67","author":"Rao","year":"1988","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP-2018-0489_bb0095","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/j.1365-2796.1991.tb00403.x","article-title":"Cardiovascular risk factors in primary hyperparathyroidism: a 15-year follow-up of operated and unoperated cases","volume":"230","author":"Lind","year":"1991","journal-title":"J Intern Med"},{"key":"10.4158\/EP-2018-0489_bb0100","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0140-6736(87)91906-4","article-title":"Survival and renal function in untreated hypercalcaemia. Population-based cohort study with 14 years of follow-up","volume":"1","author":"Palmer","year":"1987","journal-title":"Lancet"},{"key":"10.4158\/EP-2018-0489_bb0105","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1016\/j.surg.2013.06.051","article-title":"The prevalence of undiagnosed and unrecognized primary hyperparathyroidism: a population-based analysis from the electronic medical record","volume":"154","author":"Press","year":"2013","journal-title":"Surgery"},{"key":"10.4158\/EP-2018-0489_bb0110","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1097\/SLA.0000000000002370","article-title":"Failure to diagnose hyperparathyroidism in 10,432 patients with hypercalcemia: opportunities for system-level intervention to increase surgical referrals and cure","volume":"266","author":"Balentine","year":"2017","journal-title":"Ann Surg"},{"key":"10.4158\/EP-2018-0489_bb0115","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1097\/SLA.0000000000002474","article-title":"Surgery for primary hyperparathyroidism: adherence to consensus guidelines in an academic health system","volume":"269","author":"Kuo","year":"2019","journal-title":"Ann Surg"},{"key":"10.4158\/EP-2018-0489_bb0120","doi-asserted-by":"crossref","first-page":"3213","DOI":"10.1210\/jc.2013-1518","article-title":"Bone mineral density evolution after successful parathyroidectomy in patients with normocalcemic primary hyperparathyroidism","volume":"98","author":"Koumakis","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP-2018-0489_bb0125","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/s00774-015-0673-3","article-title":"Normocalcemic hyperparathyroidism is associated with complications similar to those of hypercalcemic hyperparathyroidism","volume":"34","author":"Tuna","year":"2016","journal-title":"J Bone Miner Metab"}],"container-title":["Endocrine Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X20359048?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X20359048?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T22:06:29Z","timestamp":1761516389000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1530891X20359048"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5]]},"references-count":24,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019,5]]}},"alternative-id":["S1530891X20359048"],"URL":"https:\/\/doi.org\/10.4158\/ep-2018-0489","relation":{},"ISSN":["1530-891X"],"issn-type":[{"value":"1530-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2019,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Biochemical Dynamics of Untreated Primary Hyperparathyroidism: an Observational Study","name":"articletitle","label":"Article Title"},{"value":"Endocrine Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.4158\/EP-2018-0489","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}